Tau- and amyloid-PET imaging have revealed increased cortical tau and cortical as well as subcortical beta-amyloid binding in PDD compared with PD-MCI and cognitively unimpaired PD patients (Petrou et al. 2015; Shah et al. 2016; Tang et al. 2023). Here, MAPT is linked to Parkinson disease.